Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 6/2013

01.06.2013 | Maternal-Fetal Medicine

Down Syndrome: what do pregnant women know about their individual risk? A prospective trial

verfasst von: Alexander Strauss, Ivo Markus Heer, Fritz Spelsberg, Carolin Strauss

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Down Syndrome is the most common chromosomal abnormality causing intellectual disability in western countries. The incidence relates directly to maternal age. Mothers have to face two risks when prenatal diagnosis is concerned: the probability of a congenital aneuploidy in their fetus, on the one hand, and the procedure-related risk of an invasive prenatal intervention, on the other hand. Women need precise information to deal with these risks. The aim of the study was to evaluate women’s knowledge about the individual risk of their fetus being affected by Down Syndrome.

Materials and methods

A structured questionnaire was distributed among all pregnant women who visited the prenatal care unit at Munich University Hospital, Campus Großhadern. Data evaluation was performed using Microsoft Excel 2003 and SPSS 12.0 for Windows. Statistical analysis was achieved by applying the Student t test, with statistical significance defined as p < 0.05.

Results

The data of 237 out of 246 women (96 %) were analyzed. The median gestational age of the study group was 20 (5/7) weeks of gestation [range 5 (1/7)–38 (4/7)]. The median maternal age was 32 years (range 20–41). The collective consisted of 52 % nulliparous, 34 % primiparous and 14 % multiparous women. Their educational history varied with 57 % women who attended high school and 43 % secondary school. Seventy-eight percent (185/237) of these mothers were aware of the fact that a risk of fetal aneuploidy exists, but 22 % (51/237) had never even considered this as an individual risk in their fetus. Most study participants (84 %, 155/185) realized the risk of fetal aneuploidy before conception or at least in early pregnancy. Only 5 % (10/185) of women within late pregnancy considered a chromosomal abnormality as a forthcoming risk for the first time as late as in the second or third trimester. Overall, the women estimated the risk of Down Syndrome being present in their fetus in a ratio of 1:33 (range 1–9,000:10,000); 67 % overestimated the risk and 23 % underrated their individual risk by at least a factor of 2. Only 10 % of the women had a realistic idea (within double standard deviation) of their age-dependent specific risk (p < 0.001). The patient’s self-risk assessment was influenced by factors such as personal experience (69 %), counseling by health-care professionals (19 %) or information from different media (19 %). The mother’s self-risk assessment was independent of maternal age, education parity or gestational age.

Discussion

Information transfer to patients concerning prenatal medicine is only successful to a certain extent, as pregnant women substantially overrate the risk of congenital handicaps in their fetuses. The need for a more comprehensive instruction of parents is not limited to particular subgroups. Health-care professionals and media are called upon to compensate for the apparent information deficits in parents and improve the public awareness of Down Syndrome.
Literatur
1.
Zurück zum Zitat Egan JF, Smith K, Timms D, Bolnick JM, Campbell WA, Benn PA (2011) Demographic differences in Down syndrome livebirths in the US from 1989 to 2006. Prenat Diagn 31(4):389–394PubMedCrossRef Egan JF, Smith K, Timms D, Bolnick JM, Campbell WA, Benn PA (2011) Demographic differences in Down syndrome livebirths in the US from 1989 to 2006. Prenat Diagn 31(4):389–394PubMedCrossRef
2.
Zurück zum Zitat De Graaf G, Haveman M, Hochstenbach R, Engelen J, Gerssen-Schoorl K, Poddighe P, Smeets D, van Hove G (2011) Changes in yearly birth prevalence rates of children with Down Syndrome in the period 1986–2007 in The Netherlands. J Intellect Disabil Res 55(5):462–473PubMedCrossRef De Graaf G, Haveman M, Hochstenbach R, Engelen J, Gerssen-Schoorl K, Poddighe P, Smeets D, van Hove G (2011) Changes in yearly birth prevalence rates of children with Down Syndrome in the period 1986–2007 in The Netherlands. J Intellect Disabil Res 55(5):462–473PubMedCrossRef
3.
Zurück zum Zitat Hackelöer BJ (2006) Update Pränataldiagnostik. Der Gynäkologe 39(4):283–292CrossRef Hackelöer BJ (2006) Update Pränataldiagnostik. Der Gynäkologe 39(4):283–292CrossRef
4.
Zurück zum Zitat Caughey AB, Hopkins LM, Norton ME (2006) Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. Obstet Gynecol 108:612–616PubMedCrossRef Caughey AB, Hopkins LM, Norton ME (2006) Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. Obstet Gynecol 108:612–616PubMedCrossRef
5.
Zurück zum Zitat Wapner R, Thom E, Simpson JL, Pergament E, Silver R, Filkins K, Platt L, for the First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group (2003) First-trimester screening for trisomies 21 and 18. N Engl J Med 349:1405–1413PubMedCrossRef Wapner R, Thom E, Simpson JL, Pergament E, Silver R, Filkins K, Platt L, for the First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group (2003) First-trimester screening for trisomies 21 and 18. N Engl J Med 349:1405–1413PubMedCrossRef
6.
Zurück zum Zitat Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O (2005) Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 25(3):221–226PubMedCrossRef Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O (2005) Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 25(3):221–226PubMedCrossRef
7.
Zurück zum Zitat Tyzack K, Wallance E (2003) Down Syndrome: what do health professionals know? Aust NZ J Obstet Gynaecol 43:217–221CrossRef Tyzack K, Wallance E (2003) Down Syndrome: what do health professionals know? Aust NZ J Obstet Gynaecol 43:217–221CrossRef
8.
Zurück zum Zitat Cuckle HE, Wald NJ, Thompson SG (1987) Estimating a woman’s risk of having a pregnancy associated with Down’s syndrome using her age and serum alpha-fetoprotein level. BJOG 94:387–402CrossRef Cuckle HE, Wald NJ, Thompson SG (1987) Estimating a woman’s risk of having a pregnancy associated with Down’s syndrome using her age and serum alpha-fetoprotein level. BJOG 94:387–402CrossRef
9.
Zurück zum Zitat Bishop AJ, Marteau TM, Armstrong D, Chitty LS, Longworth L, Buxton MJ, Berlin C (2004) Women and health care professionals' preferences for Down's Syndrome screening tests: conjoint analysis study. BJOG 111(8):775–779PubMedCrossRef Bishop AJ, Marteau TM, Armstrong D, Chitty LS, Longworth L, Buxton MJ, Berlin C (2004) Women and health care professionals' preferences for Down's Syndrome screening tests: conjoint analysis study. BJOG 111(8):775–779PubMedCrossRef
10.
Zurück zum Zitat Munim S, Khawaja NA, Qureshi R (2004) Knowledge and awareness of pregnant women about ultrasounds scanning and prenatal diagnosis. J Pak Med Assoc 54(11):553–555PubMed Munim S, Khawaja NA, Qureshi R (2004) Knowledge and awareness of pregnant women about ultrasounds scanning and prenatal diagnosis. J Pak Med Assoc 54(11):553–555PubMed
11.
Zurück zum Zitat Wonkam A, Njamnshi AK, Angwafo FF (2006) Knowledge and attitudes concerning medical genetics amongst physicians and medical students in Cameroon. Genet Med 8(6):331–338PubMedCrossRef Wonkam A, Njamnshi AK, Angwafo FF (2006) Knowledge and attitudes concerning medical genetics amongst physicians and medical students in Cameroon. Genet Med 8(6):331–338PubMedCrossRef
12.
Zurück zum Zitat Santalahti P, Hemminki E, Latikka AM, Ryynanrn M (1998) Women's decision-making in prenatal screening. Soc Sci Med 46(8):1067–1076PubMedCrossRef Santalahti P, Hemminki E, Latikka AM, Ryynanrn M (1998) Women's decision-making in prenatal screening. Soc Sci Med 46(8):1067–1076PubMedCrossRef
13.
Zurück zum Zitat De Vigan C, Vodovar V, Goujard J, Garel M, Vayssière C, Goffinet F (2002) Mothers' knowledge of screening for trisomy 21 in 1999: a survey in Paris maternity units. Eur J Obstet Gynecol Reprod Biol 104(1):14–20PubMedCrossRef De Vigan C, Vodovar V, Goujard J, Garel M, Vayssière C, Goffinet F (2002) Mothers' knowledge of screening for trisomy 21 in 1999: a survey in Paris maternity units. Eur J Obstet Gynecol Reprod Biol 104(1):14–20PubMedCrossRef
14.
Zurück zum Zitat Rowe HJ, Fisher JR, Quinlivan JA (2006) Are pregnant Australian women well informed about prenatal genetic screening? A systematic investigation using the Multidimensional Measure of Informed Choice. Aust N Z J Obstet Gynaecol 46(5):433–439PubMedCrossRef Rowe HJ, Fisher JR, Quinlivan JA (2006) Are pregnant Australian women well informed about prenatal genetic screening? A systematic investigation using the Multidimensional Measure of Informed Choice. Aust N Z J Obstet Gynaecol 46(5):433–439PubMedCrossRef
15.
Zurück zum Zitat Cleary-Goldmann J, Morgan MA, Malone FD, Robinson JN, D`Alton, Schulkin J (2006) Screening for Down Syndrome: practice patterns and knowledge of obstetricians and gynecologists. Obstet Gynecol 107(1):11–17CrossRef Cleary-Goldmann J, Morgan MA, Malone FD, Robinson JN, D`Alton, Schulkin J (2006) Screening for Down Syndrome: practice patterns and knowledge of obstetricians and gynecologists. Obstet Gynecol 107(1):11–17CrossRef
16.
Zurück zum Zitat Müller MA, Bleker OP, Bonsel GJ, Bilardo CM (2006) Women's opinions on the offer and use of nuchal translucency screening for Down Syndrome. Prenat Diagn 26:105–111PubMedCrossRef Müller MA, Bleker OP, Bonsel GJ, Bilardo CM (2006) Women's opinions on the offer and use of nuchal translucency screening for Down Syndrome. Prenat Diagn 26:105–111PubMedCrossRef
17.
Zurück zum Zitat Antley RM, Seidenfelder MJ (1978) A detailed description of mothers' knowledge before genetic counselling for Down Syndrome: part I. Am J Med Genet 2(4):357–364PubMedCrossRef Antley RM, Seidenfelder MJ (1978) A detailed description of mothers' knowledge before genetic counselling for Down Syndrome: part I. Am J Med Genet 2(4):357–364PubMedCrossRef
18.
Zurück zum Zitat Bramwell R, Carter D (2001) A exploration of midwives' and obstetricians' knowledge of genetic screening in pregnancy and their perception of appropriate counselling. Midwifery 17(2):133–141PubMedCrossRef Bramwell R, Carter D (2001) A exploration of midwives' and obstetricians' knowledge of genetic screening in pregnancy and their perception of appropriate counselling. Midwifery 17(2):133–141PubMedCrossRef
19.
Zurück zum Zitat Nicolaides KH, Chervenak FA, McCullough LB, Avgidou K, Papageorghiou (2005) Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21. Am J Obstet Gynecol 193:322–326PubMedCrossRef Nicolaides KH, Chervenak FA, McCullough LB, Avgidou K, Papageorghiou (2005) Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21. Am J Obstet Gynecol 193:322–326PubMedCrossRef
Metadaten
Titel
Down Syndrome: what do pregnant women know about their individual risk? A prospective trial
verfasst von
Alexander Strauss
Ivo Markus Heer
Fritz Spelsberg
Carolin Strauss
Publikationsdatum
01.06.2013
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 6/2013
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-012-2707-6

Weitere Artikel der Ausgabe 6/2013

Archives of Gynecology and Obstetrics 6/2013 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.